4/A//SEC Filing
Pharmagen, Inc. 4/A
Accession 0001135432-14-000021
CIK 0001470915operating
Filed
Jul 8, 8:00 PM ET
Accepted
Jul 9, 12:34 PM ET
Size
5.9 KB
Accession
0001135432-14-000021
Insider Transaction Report
Form 4/AAmended
Pharmagen, Inc.PHRX
Perry Stephen M.
DirectorOther
Transactions
- Other
Common Stock
2014-06-17−11,100,000→ 0 total(indirect: By LLC)
Footnotes (2)
- [F1]The transaction reported on the original Form 4, filed with the Securities and Exchange Commission on June 18, 2014, was never consummated. As a result, the reporting person never acquired beneficial ownership over the shares identified in the original Form 4.
- [F2]Kymanox, LLC, an Illinois limited liability company, was to be the registered owner of the shares identified in the original Form 4 filed with the Securities and Exchange Commission on June 18, 2014. As indicated in the previous footnote, the consummation of the transaction pursuant to which Kymanox was to acquire the shares identified in the original Form 4 was never consummated. The reporting person, Stephen Perry, is the President and Chief Executive Officer of Kymanox, LLC. Because the transaction identified in the original Form 4 was never consummated, the reporting person never acquired beneficial ownership over the shares identified therein.
Documents
Issuer
Pharmagen, Inc.
CIK 0001470915
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001470915
Filing Metadata
- Form type
- 4/A
- Filed
- Jul 8, 8:00 PM ET
- Accepted
- Jul 9, 12:34 PM ET
- Size
- 5.9 KB